NIAGEN BIOSCIENCE, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $31.7M | $28.2M |
| FY2022 | — | $28.7M | $20.3M |
| FY2023 | — | $28.5M | $27.2M |
| FY2024 | — | $46.1M | $44.5M |
| FY2025 | — | $76.5M | $64.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $31.7M | $28.2M |
| FY2022 | — | $28.7M | $20.3M |
| FY2023 | — | $28.5M | $27.2M |
| FY2024 | — | $46.1M | $44.5M |
| FY2025 | — | $76.5M | $64.8M |